Brooks O'Neil
Stock Analyst at Lake Street
(0.60)
# 4,038
Out of 5,182 analysts
34
Total ratings
26.47%
Success rate
-20.74%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $3.92 | +155.10% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.91 | +104.60% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $20.10 | -40.30% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.91 | +62.93% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.36 | +747.46% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $115.17 | -4.49% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $10.63 | +182.22% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.17 | +523.50% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $37.10 | +48.25% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $11.25 | +60.00% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.87 | +125.48% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.38 | +110.08% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.95 | +4.21% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $330 | $4.50 | +7,233.33% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $17.23 | +639.99% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.92
Upside: +155.10%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.91
Upside: +104.60%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $20.10
Upside: -40.30%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.91
Upside: +62.93%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.36
Upside: +747.46%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $115.17
Upside: -4.49%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $10.63
Upside: +182.22%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.17
Upside: +523.50%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $37.10
Upside: +48.25%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $11.25
Upside: +60.00%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.87
Upside: +125.48%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.38
Upside: +110.08%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.95
Upside: +4.21%
Apr 8, 2022
Initiates: Buy
Price Target: $330
Current: $4.50
Upside: +7,233.33%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $17.23
Upside: +639.99%